List of Excipients in API selumetinib
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing selumetinib
Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
---|---|---|---|---|---|
AstraZeneca Pharmaceuticals LP | KOSELUGO | selumetinib | 0310-0610 | AMMONIA | 2027-04-10 |
AstraZeneca Pharmaceuticals LP | KOSELUGO | selumetinib | 0310-0610 | BUTYL ALCOHOL | 2027-04-10 |
AstraZeneca Pharmaceuticals LP | KOSELUGO | selumetinib | 0310-0610 | CARRAGEENAN | 2027-04-10 |
AstraZeneca Pharmaceuticals LP | KOSELUGO | selumetinib | 0310-0610 | FERROSOFERRIC OXIDE | 2027-04-10 |
AstraZeneca Pharmaceuticals LP | KOSELUGO | selumetinib | 0310-0610 | HYPROMELLOSE | 2027-04-10 |
>Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for selumetinib
Excipient focus: AMMONIA
selumetinib drug variants containing AMMONIA
Company | Ingredient | NDC |
---|---|---|
AstraZeneca Pharmaceuticals LP | selumetinib | 0310-0610 |
>Company | >Ingredient | >NDC |
selumetinib drug variants not containing AMMONIA
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: BUTYL ALCOHOL
selumetinib drug variants containing BUTYL ALCOHOL
Company | Ingredient | NDC |
---|---|---|
AstraZeneca Pharmaceuticals LP | selumetinib | 0310-0610 |
>Company | >Ingredient | >NDC |
selumetinib drug variants not containing BUTYL ALCOHOL
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: CARRAGEENAN
selumetinib drug variants containing CARRAGEENAN
Company | Ingredient | NDC |
---|---|---|
AstraZeneca Pharmaceuticals LP | selumetinib | 0310-0610 |
>Company | >Ingredient | >NDC |
selumetinib drug variants not containing CARRAGEENAN
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
selumetinib drug variants containing FERROSOFERRIC OXIDE
Company | Ingredient | NDC |
---|---|---|
AstraZeneca Pharmaceuticals LP | selumetinib | 0310-0610 |
>Company | >Ingredient | >NDC |
selumetinib drug variants not containing FERROSOFERRIC OXIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
selumetinib drug variants containing HYPROMELLOSE
Company | Ingredient | NDC |
---|---|---|
AstraZeneca Pharmaceuticals LP | selumetinib | 0310-0610 |
>Company | >Ingredient | >NDC |
selumetinib drug variants not containing HYPROMELLOSE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: ISOPROPYL ALCOHOL
selumetinib drug variants containing ISOPROPYL ALCOHOL
Company | Ingredient | NDC |
---|---|---|
AstraZeneca Pharmaceuticals LP | selumetinib | 0310-0610 |
>Company | >Ingredient | >NDC |
selumetinib drug variants not containing ISOPROPYL ALCOHOL
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: POTASSIUM CHLORIDE
selumetinib drug variants containing POTASSIUM CHLORIDE
Company | Ingredient | NDC |
---|---|---|
AstraZeneca Pharmaceuticals LP | selumetinib | 0310-0610 |
>Company | >Ingredient | >NDC |
selumetinib drug variants not containing POTASSIUM CHLORIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
selumetinib drug variants containing PROPYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
AstraZeneca Pharmaceuticals LP | selumetinib | 0310-0610 |
>Company | >Ingredient | >NDC |
selumetinib drug variants not containing PROPYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: SHELLAC
selumetinib drug variants containing SHELLAC
Company | Ingredient | NDC |
---|---|---|
AstraZeneca Pharmaceuticals LP | selumetinib | 0310-0610 |
>Company | >Ingredient | >NDC |
selumetinib drug variants not containing SHELLAC
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
selumetinib drug variants containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
AstraZeneca Pharmaceuticals LP | selumetinib | 0310-0610 |
>Company | >Ingredient | >NDC |
selumetinib drug variants not containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: TOCOPHERSOLAN
selumetinib drug variants containing TOCOPHERSOLAN
Company | Ingredient | NDC |
---|---|---|
AstraZeneca Pharmaceuticals LP | selumetinib | 0310-0610 |
>Company | >Ingredient | >NDC |
selumetinib drug variants not containing TOCOPHERSOLAN
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: WATER
selumetinib drug variants containing WATER
Company | Ingredient | NDC |
---|---|---|
AstraZeneca Pharmaceuticals LP | selumetinib | 0310-0610 |
>Company | >Ingredient | >NDC |
selumetinib drug variants not containing WATER
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.